Cargando…

Identification of Novel Characteristics in TP53-Mutant Hepatocellular Carcinoma Using Bioinformatics

Background: TP53 mutations are the most frequent mutations in hepatocellular carcinoma (HCC) and affect the occurrence and development of this cancer type. Therefore, it is essential to clarify the function and mechanism of TP53 mutations in HCC. Methods: We performed a sequence of bioinformatic ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yang, Qu, Yajuan, Li, Zhaopeng, Tan, Zhiyong, Lei, Youming, Bai, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149291/ https://www.ncbi.nlm.nih.gov/pubmed/35651938 http://dx.doi.org/10.3389/fgene.2022.874805

Ejemplares similares

Genomic Analysis Revealed New Oncogenic Signatures in TP53-Mutant Hepatocellular Carcinoma
por: Kancherla, Venkatesh, et al.
Publicado: (2018)

Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant TP53 or Wild-Type CTNNB1 Gene
por: Lin, Jiunn-Chang, et al.
Publicado: (2021)

TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study
por: Tao, Yuting, et al.
Publicado: (2022)

Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma
por: Kumar, Sonu, et al.
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2021)

The TP53-Related Signature Predicts Immune Cell Infiltration, Therapeutic Response, and Prognosis in Patients With Esophageal Carcinoma
por: Zhang, Hongpan, et al.
Publicado: (2021)

Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome
por: Paduano, Francesco, et al.
Publicado: (2021)

Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zeng, Xian-Chang, et al.
Publicado: (2020)

Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods
por: Li, Zhuolin, et al.
Publicado: (2021)

TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
por: Halvorsen, Ann R., et al.
Publicado: (2016)

Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches
por: Chen, Huaping, et al.
Publicado: (2021)

The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
por: Yang, Chang, et al.
Publicado: (2021)

Identification of a TP53 Mutation in a Patient With Li-Fraumeni Syndrome and Not Meeting the Revised Chompret Criteria: A Case Report
por: Iwasaki, Monika, et al.
Publicado: (2023)

TP53 R273C Mutation Is Associated With Poor Prognosis in LGG Patients
por: Zhang, Jian, et al.
Publicado: (2022)

Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis
por: Zhao, Lin, et al.
Publicado: (2022)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022)

A cellular senescence-related genes model allows for prognosis and treatment stratification of hepatocellular carcinoma: A bioinformatics analysis and experimental verification
por: Li, Jiaming, et al.
Publicado: (2023)

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

TP53/MicroRNA Interplay in Hepatocellular Carcinoma
por: Pollutri, Daniela, et al.
Publicado: (2016)

Comprehensive bioinformatics analysis of the TP53 signaling pathway in Wilms’ tumor
por: He, Changjing, et al.
Publicado: (2020)

Identification of TP53 mutation associated-immunotype and prediction of survival in patients with hepatocellular carcinoma
por: Shi, Muqi, et al.
Publicado: (2020)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma
por: Jiang, Wenxiu, et al.
Publicado: (2023)

Identification and Validation of the Diagnostic Characteristic Genes of Ovarian Cancer by Bioinformatics and Machine Learning
por: Liu, Jinya, et al.
Publicado: (2022)

Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and TP53 Mutant Porcine Models Reveals Overlooked Challenges in Precision Modeling of Human Diseases
por: Rubinstein, Clifford Dustin, et al.
Publicado: (2021)

Bioinformatics Analysis of Differentially Expressed Rhythm Genes in Liver Hepatocellular Carcinoma
por: Liu, Huaifeng, et al.
Publicado: (2021)

Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments
por: Hu, Xueting, et al.
Publicado: (2022)

Association of mRNA expression of TP53 and the TP53 codon 72 Arg/Pro gene polymorphism with colorectal cancer risk in Asian population: a bioinformatics analysis and meta-analysis
por: Dong, Zhiyong, et al.
Publicado: (2018)

Erratum to comprehensive bioinformatics analysis of the TP53 signaling pathway in Wilms’ tumor
por: He, Changjing, et al.
Publicado: (2021)

Case Report: Pulmonary sarcomatoid carcinoma complicating TP53 mutation treated successfully with Tislelizumab combined with Anlotinib—a case report
por: Li, Yu-Feng, et al.
Publicado: (2022)

Gene Coexpression Analyses Differentiate Networks Associated with Diverse Cancers Harboring TP53 Missense or Null Mutations
por: Oros Klein, Kathleen, et al.
Publicado: (2016)

Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222
por: Enciso-Mora, V, et al.
Publicado: (2013)

Blood functional assay for rapid clinical interpretation of germline TP53 variants
por: Raad, Sabine, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated With Clinical Outcome in Hepatocellular Carcinoma
por: Li, Yubin, et al.
Publicado: (2020)

Identification of New Therapeutic Targets for Gastric Cancer With Bioinformatics
por: Li, Yang, et al.
Publicado: (2020)

Identification of TP53 mutation-associated prognostic genes and investigation of the immune cell infiltration in patients with hepatocellular carcinoma
por: Yang, Qijun, et al.
Publicado: (2023)

Identification of the potential roles of ring finger protein 8 in TP53-mutant breast cancer
por: Zhao, Feng, et al.
Publicado: (2021)

Epidermal Growth Factor Receptor-mutated Lung Cancer as the Initial Manifestation of Germline TP53 Mutation Associated Cancer
por: Pathak, Surabhi, et al.
Publicado: (2018)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jdd0dusrqt36ilcn0sk6revnql